Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, a quantitative neuromuscular transmission monitor, which supports neuromuscular blockade management from induction to recovery; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance sensor to measure the tissue's opposition to carrying an alternating electrical current. It also provides additional products, including CliniSenz Analyzer and OnZurf Probe. The company has a strategic connectivity and licensing agreement with Masimo to develop, manufacture, market, and distribute products that can connect to the Masimo Root patient monitoring system; license agreement with Fukuda Denshi Co. Ltd. to license TetraGraph technology; and license agreement with CoreSpiron (Henan) Co Ltd. to manufacture and sell ExSpiron system. Senzime AB (publ) was incorporated in 1999 and is headquartered in Uppsala, Sweden.

CEO

Mr. Philip Siberg

Employees

Country

ISIN

SE0002478776

Listings

0 Comments

Share your thoughts

FAQ

What is Senzime AB stock price today?▼

The current price of SNZZF is $0.48 USD — it has decreased by -31.83% in the past 24 hours. Watch Senzime AB stock price performance more closely on the chart.

What is Senzime AB stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Senzime AB stocks are traded under the ticker SNZZF.

Is Senzime AB stock price growing?▼

SNZZF stock has risen by +0% compared to the previous week, the month change is a -31.83% fall, over the last year Senzime AB has showed a -13.24% decrease.

What is Senzime AB market cap?▼

Today Senzime AB has the market capitalization of 75.02M

When is the next Senzime AB earnings date?▼

Senzime AB is going to release the next earnings report on April 22, 2026.

What is Senzime AB revenue for the last year?▼

Senzime AB revenue for the last year amounts to 30.43M USD.

What is Senzime AB net income for the last year?▼

SNZZF net income for the last year is -39.59M USD.

How many employees does Senzime AB have?▼

As of April 06, 2026, the company has 54 employees.

In which sector is Senzime AB located?▼

Senzime AB operates in the Health Care sector.

When did Senzime AB complete a stock split?▼

Senzime AB has not had any recent stock splits.

Where is Senzime AB headquartered?▼

Senzime AB is headquartered in Uppsala, SE.